These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population. van der Weide K, Loovers H, Pondman K, Bogers J, van der Straaten T, Langemeijer E, Cohen D, Commandeur J, van der Weide J. Pharmacogenomics J; 2017 Oct; 17(5):471-478. PubMed ID: 27168101 [Abstract] [Full Text] [Related]
25. Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample. Dettling M, Cascorbi I, Roots I, Mueller-Oerlinghausen B. Arch Gen Psychiatry; 2001 Jan; 58(1):93-4. PubMed ID: 11146763 [No Abstract] [Full Text] [Related]
27. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients. Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E. Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073 [Abstract] [Full Text] [Related]
29. HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry. Konte B, Walters JTR, Rujescu D, Legge SE, Pardiñas AF, Cohen D, Pirmohamed M, Tiihonen J, Hartmann AM, Bogers JP, van der Weide J, van der Weide K, Putkonen A, Repo-Tiihonen E, Hallikainen T, Silva E, Ingimarsson O, Sigurdsson E, Kennedy JL, Sullivan PF, Rietschel M, Breen G, Stefansson H, Stefansson K, Collier DA, O'Donovan MC, Giegling I. Transl Psychiatry; 2021 Apr 12; 11(1):214. PubMed ID: 33846298 [Abstract] [Full Text] [Related]
30. The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies. Li XH, Zhong XM, Lu L, Zheng W, Wang SB, Rao WW, Wang S, Ng CH, Ungvari GS, Wang G, Xiang YT. Psychol Med; 2020 Mar 12; 50(4):583-594. PubMed ID: 30857568 [Abstract] [Full Text] [Related]
31. HLA associations in clozapine-induced agranulocytosis. Yunis JJ, Corzo D, Salazar M, Lieberman JA, Howard A, Yunis EJ. Blood; 1995 Aug 01; 86(3):1177-83. PubMed ID: 7620171 [Abstract] [Full Text] [Related]
34. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis. Raveendranathan D, Sharma E, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN. Gen Hosp Psychiatry; 2013 Aug 01; 35(5):574.e5-6. PubMed ID: 22902258 [Abstract] [Full Text] [Related]
35. Human leukocyte antigen-DRB1*04:05 might be associated with the development of clozapine-induced agranulocytosis in a Japanese patient with schizophrenia. Hirakawa H, Terao T, Muronaga M, Ishii N. Aust N Z J Psychiatry; 2020 May 01; 54(5):542-543. PubMed ID: 31718253 [No Abstract] [Full Text] [Related]
36. No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis. Claas FH, Abbott PA, Witvliet MD, D'Amaro J, Barnes PM, Krupp P. Drug Saf; 1992 May 01; 7 Suppl 1():3-6. PubMed ID: 1503675 [Abstract] [Full Text] [Related]
37. Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms? Mosyagin I, Cascorbi I, Schaub R, Krüger T, Dettling M. J Clin Psychopharmacol; 2005 Oct 01; 25(5):435-40. PubMed ID: 16160618 [Abstract] [Full Text] [Related]